OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SOS1 and KSR1 modulate MEK inhibitor responsiveness to target resistant cell populations based on PI3K and KRAS mutation status
Brianna R. Daley, Heidi M. Vieira, Chaitra Rao, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 47
Open Access | Times Cited: 14
Brianna R. Daley, Heidi M. Vieira, Chaitra Rao, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 47
Open Access | Times Cited: 14
Showing 14 citing articles:
Drug tolerant persister cell plasticity in cancer: A revolutionary strategy for more effective anticancer therapies
Jun He, Zejing Qiu, Jingjing Fan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Jun He, Zejing Qiu, Jingjing Fan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Targeting MEK in non-small cell lung cancer
Matthew S Lara, Collin M. Blakely, Jonathan W. Riess
Current Problems in Cancer (2024) Vol. 49, pp. 101065-101065
Open Access | Times Cited: 5
Matthew S Lara, Collin M. Blakely, Jonathan W. Riess
Current Problems in Cancer (2024) Vol. 49, pp. 101065-101065
Open Access | Times Cited: 5
Sos1 ablation alters focal adhesion dynamics and increases Mmp2/9-dependent gelatinase activity in primary mouse embryonic fibroblasts
Pilar Liceras-Boillos, Rósula García‐Navas, Clara Llorente-González, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Pilar Liceras-Boillos, Rósula García‐Navas, Clara Llorente-González, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
VRK2 kinase pathogenic pathways in cancer and neurological diseases
Pedro A. Lazo
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2025), pp. 119949-119949
Closed Access
Pedro A. Lazo
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2025), pp. 119949-119949
Closed Access
LINC02167 stabilizes KSR1 mRNA in an m5C-dependent manner to regulate the ERK/MAPK signaling pathway and promotes colorectal cancer metastasis
Junwen Qi, Tao Jiang, Bowen Liu, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Junwen Qi, Tao Jiang, Bowen Liu, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
KRAS mutations in colorectal cancer: impacts on tumor microenvironment and therapeutic implications
Alireza S. Emami, Pouya Mahdavi Sharif, Nima Rezaei
Expert Opinion on Therapeutic Targets (2025), pp. 1-23
Closed Access
Alireza S. Emami, Pouya Mahdavi Sharif, Nima Rezaei
Expert Opinion on Therapeutic Targets (2025), pp. 1-23
Closed Access
ERK1/2-MAPK signaling: Metabolic, organellar, and cytoskeletal interactions
Ana Martín-Vega, Melanie H. Cobb
Current Opinion in Cell Biology (2025) Vol. 95, pp. 102526-102526
Closed Access
Ana Martín-Vega, Melanie H. Cobb
Current Opinion in Cell Biology (2025) Vol. 95, pp. 102526-102526
Closed Access
PDP1 promotes KRAS mutant colorectal cancer progression by serving as a scaffold for BRAF and MEK1
Ming Yuan, Chi Zhang, Shaopeng Chen, et al.
Cancer Letters (2024) Vol. 597, pp. 217007-217007
Open Access | Times Cited: 3
Ming Yuan, Chi Zhang, Shaopeng Chen, et al.
Cancer Letters (2024) Vol. 597, pp. 217007-217007
Open Access | Times Cited: 3
Current perspectives of KRAS in non-small cell lung cancer
Ethan Harris, Rajat Thawani
Current Problems in Cancer (2024) Vol. 51, pp. 101106-101106
Closed Access | Times Cited: 3
Ethan Harris, Rajat Thawani
Current Problems in Cancer (2024) Vol. 51, pp. 101106-101106
Closed Access | Times Cited: 3
Protocol for modeling acquired resistance to targeted therapeutics in adherent and suspension cancer cell lines via in situ resistance assay
Nancy E. Sealover, Jacob M. Hughes, Patricia L. Theard, et al.
STAR Protocols (2024) Vol. 5, Iss. 4, pp. 103361-103361
Open Access | Times Cited: 3
Nancy E. Sealover, Jacob M. Hughes, Patricia L. Theard, et al.
STAR Protocols (2024) Vol. 5, Iss. 4, pp. 103361-103361
Open Access | Times Cited: 3
Patricia L. Theard, Amanda J. Linke, Nancy E. Sealover, et al.
Molecular Oncology (2023) Vol. 18, Iss. 3, pp. 641-661
Open Access | Times Cited: 4
SOS2 regulates the threshold of mutantEGFR-dependent oncogenesis
Patricia L. Theard, Amanda J. Linke, Nancy E. Sealover, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Patricia L. Theard, Amanda J. Linke, Nancy E. Sealover, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
SOS1 inhibition enhances the efficacy of and delays resistance to G12C inhibitors in lung adenocarcinoma
Brianna R. Daley, Nancy E. Sealover, Erin Sheffels, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Brianna R. Daley, Nancy E. Sealover, Erin Sheffels, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Mediating kinase activity in Ras-mutant cancer: potential for an individualised approach?
Fiona Healy, Amy L. Turner, Vanessa Marensi, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Fiona Healy, Amy L. Turner, Vanessa Marensi, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
